» Articles » PMID: 29903923

MR Imaging Features of Anaplastic Pleomorphic Xanthoastrocytoma Mimicking High-Grade Astrocytoma

Overview
Specialty Neurology
Date 2018 Jun 16
PMID 29903923
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: Anaplastic pleomorphic xanthoastrocytoma, which has been recently defined as a distinct entity in the 2016 World Health Organization classification, may exhibit aggressive clinical behavior and relatively worse prognosis than pleomorphic xanthoastrocytoma. This study aimed to investigate whether there were any differences in MR imaging characteristics between these 2 tumors.

Materials And Methods: This retrospective study included 9 patients with anaplastic pleomorphic xanthoastrocytoma and 10 patients with pleomorphic xanthoastrocytoma who underwent MR imaging before an operation. DWI was performed in 17 patients (8 with anaplastic pleomorphic xanthoastrocytoma, 9 with pleomorphic xanthoastrocytoma); and DSC-PWI, in 9 patients (5 with anaplastic pleomorphic xanthoastrocytoma, 4 with pleomorphic xanthoastrocytoma). Demographics, conventional imaging characteristics (location, size, cystic degeneration, enhancement, peritumoral edema, and leptomeningeal contact), minimum relative ADC ratio, and maximum relative CBV ratio were evaluated between the anaplastic pleomorphic xanthoastrocytoma and pleomorphic xanthoastrocytoma groups.

Results: Anaplastic pleomorphic xanthoastrocytoma was more likely to demonstrate high-grade features than pleomorphic xanthoastrocytoma, including greater maximum tumor diameter (4.7 ± 0.6 cm versus 3.1 ± 1.1 cm, = .001), more frequent heterogeneous contrast enhancement of solid portions (88.9% versus 20.0%, = .01), more obvious peritumoral edema (2.3 ± 0.9 cm versus 1.0 ± 0.9 cm, = .008), lower minimum relative ADC on DWI (1.0 ± 0.2 versus 1.5 ± 0.4, = .008), and higher maximum relative CBV on DSC-PWI (2.6 ± 0.8 versus 1.6 ± 0.2, = .036).

Conclusions: Anaplastic pleomorphic xanthoastrocytomas often have more aggressive MR imaging features mimicking high-grade astrocytomas than pleomorphic xanthoastrocytomas. DWI and DSC-PWI might be useful in the characterization and differentiation of anaplastic pleomorphic xanthoastrocytoma and pleomorphic xanthoastrocytoma.

Citing Articles

Diffusely Infiltrating Gliomas With Poor Prognosis, Promotor Mutations, and Histological Anaplastic Pleomorphic Xanthoastrocytoma-Like Appearance Classify as Mesenchymal Type of Glioblastoma, IDH-wildtype by Methylation Analysis.

Tsukamoto Y, Natsumeda M, Takahashi H, On J, Seto H, Saito T Neurosurg Pract. 2025; 4(2):e00040.

PMID: 39958377 PMC: 11810039. DOI: 10.1227/neuprac.0000000000000040.


Drug-resistant schizophrenia-like psychosis associated with temporal non-anaplastic pleomorphic xanthoastrocytoma: unusual revealing symptom of a rare pathology.

Borni M, Kammoun B, Masmoudi R, Abdelkefi M, Gouiaa N, Ayedi A Ann Med Surg (Lond). 2024; 86(10):6208-6214.

PMID: 39359786 PMC: 11444643. DOI: 10.1097/MS9.0000000000002484.


Nomogram incorporating preoperative MRI-VASARI features for differentiating intracranial extraventricular ependymoma from glioblastoma.

Yao Y, Fu Y, Zhou G, Wang X, Li L, Mao Y Quant Imaging Med Surg. 2024; 14(3):2255-2266.

PMID: 38545063 PMC: 10963811. DOI: 10.21037/qims-23-1148.


Intraventricular Pleomorphic Xanthoastrocytoma: A Case Report and Systemic Review.

Wu X, Yokoyama K, Sumita K, Tanaka Y, Tateishi U Cureus. 2024; 16(1):e52510.

PMID: 38371127 PMC: 10874249. DOI: 10.7759/cureus.52510.


Benign Glioma.

Wu P, Filley A, Miller M, Bruce J Adv Exp Med Biol. 2023; 1405:31-71.

PMID: 37452934 DOI: 10.1007/978-3-031-23705-8_2.


References
1.
Thakkar J, Dolecek T, Horbinski C, Ostrom Q, Lightner D, Barnholtz-Sloan J . Epidemiologic and molecular prognostic review of glioblastoma. Cancer Epidemiol Biomarkers Prev. 2014; 23(10):1985-96. PMC: 4185005. DOI: 10.1158/1055-9965.EPI-14-0275. View

2.
Rao A, Laack N, Giannini C, Wetmore C . Pleomorphic xanthoastrocytoma in children and adolescents. Pediatr Blood Cancer. 2010; 55(2):290-4. DOI: 10.1002/pbc.22490. View

3.
Wu X, Bandopadhayay P, Ng J, Ashley D, Chow C . The evolution of the histology in pleomorphic xanthoastrocytomas in children: a study of 15 cases. Pathology. 2011; 43(1):9-16. DOI: 10.1097/PAT.0b013e328340bb98. View

4.
Crespo-Rodriguez A, Smirniotopoulos J, Rushing E . MR and CT imaging of 24 pleomorphic xanthoastrocytomas (PXA) and a review of the literature. Neuroradiology. 2007; 49(4):307-15. DOI: 10.1007/s00234-006-0191-z. View

5.
Sugahara T, Korogi Y, Kochi M, Ikushima I, SHIGEMATU Y, Hirai T . Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging. 1999; 9(1):53-60. DOI: 10.1002/(sici)1522-2586(199901)9:1<53::aid-jmri7>3.0.co;2-2. View